This economic evaluation reports the number of therapeutic services for autism spectrum disorder that were acquired by private equity companies between 2015 and 2024.
Arnold et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: